Welcome to Escient Pharmaceuticals. We are a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. We are focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases.
Based in San Diego, we are led by an experienced team of entrepreneurs with deep roots in this region's life sciences ecosystem and specific expertise in GPCR drug discovery and development. We are funded by top-tier life science investors with a proven track record for identifying and supporting successful, next-generation companies.